These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15588887)

  • 1. Conformal radiotherapy of urinary bladder cancer.
    Muren LP; Smaaland R; Dahl O
    Radiother Oncol; 2004 Dec; 73(3):387-98. PubMed ID: 15588887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer.
    Fokdal L; Honoré H; Høyer M; Meldgaard P; Fode K; von der Maase H
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):436-44. PubMed ID: 15145160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
    van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
    Muren LP; Redpath AT; McLaren D; Rørvik J; Halvorsen OJ; Høstmark J; Bakke A; Thwaites D; Dahl O
    Radiother Oncol; 2006 Jul; 80(1):98-105. PubMed ID: 16876274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [State of the art and advances in radiotherapy for bladder cancer].
    Thariat J; Caullery M; Ginot A; Hannoun-Lévi JM; Barrière J; Buthaud X; Marcié S; Bondiau PY; Housset M; Lagrange JL; Amiel J; Gérard JP
    Prog Urol; 2009 Feb; 19(2):85-93. PubMed ID: 19168010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
    Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for bladder cancer.
    Milosevic M; Gospodarowicz M; Zietman A; Abbas F; Haustermans K; Moonen L; Rödel C; Schoenberg M; Shipley W
    Urology; 2007 Jan; 69(1 Suppl):80-92. PubMed ID: 17280910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimisation algorithm for determination of treatment margins around moving and deformable targets.
    Redpath AT; Muren LP
    Radiother Oncol; 2005 Nov; 77(2):194-201. PubMed ID: 16209894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformal external beam radiotherapy in the treatment of anal canal carcinoma: a retrospective study of a genital organ sparing technique.
    Bui T; Harvey J; Brown E; Scott M; Haines T; Davidson K
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):396-404. PubMed ID: 19695047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; von der Maase H
    Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.
    Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K
    Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs).
    Jereczek-Fossa BA; Cattani F; D'Onofrio A; Cambria R; Kowalczyk A; Corallo A; Vavassori A; Zerini D; Ivaldi GB; DeCobelli O; Orecchia R
    Radiother Oncol; 2006 Dec; 81(3):294-302. PubMed ID: 17113670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.